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Abstract
Creutefeldt-].akob disease is afata l degenerative disorder ofthe central nervous system. The
variability ofits prodromal psychiatric and neurologic maniftstation oflen obscures the diagnosis.
This paper reports a case that illustrates the complexity qf diagnosing this disease early in the
clinical course, and qffirs a briefreoieioofthe literature.
INTRODUCTI ON
C re u tz fe ld t-Jakob di sease (CJ D) is a form of nervous and menta l illn es s ass oci-
a ted with progressive ce n t ral nervou s syste m degen era tion, first described by
C re u tzfe ld t and J akob in the ea rly 1920s (1 ,2) . CJ D p rin cipall y affects th e grey
m atte r of cerebra l corte x, bra inst em , a nd th e molecul ar layer of the ce re be llu m . Lik e
o ther subacu te spongifo rm ence phalopat hies in this group (Gers tmann-St rau ssler
syndrome, kuru , scrapie, and m ink encephalopathy) , it is believed to be ca use d by
hist ologicall y un con ven tion al in fectiou s agen ts ca lled " pr ions" (3). Prions a re treat-
ment-resist ant virus-like st ruct ures whi ch differ from viruses becaus e of th eir littl e , if
a ny, nuclei c ac id core and their unique protein infectiou s co m po nent PrP27 -30. The
di sease is found worldwide with a n a pproxi ma te incid en ce of one hal f case per million
per year in the ge ne ral population. Most cases a re spo radic, but 5- 15% of cases have a
ge ne tic basis a nd have been clus te re d within fa mi lies, inheri ted as a n a u tosomal
dominan t tra it wi t h varia ble penetrance (4) . CJ D affects bo th sex es eq ua lly, with a
m ean age of onse t arou nd 60 ; however; pa tients as young as 17 and as old as 83 have
been reported. Despite isolated case reports of acc iden tal hu m an-to-hum a n transmis-
sion of CJ D (following human grow th hormon e th e rapy, co rneal t ranspla n ta t ion, and
con tamina te d e lec t roe nce phalog ram electrode implantat ion) , researchers beli eve
that direct inoculation of the age nt rem a ins the on ly proven m echanism of transmi s-
sio n. Forty-on e percent of th e cases begin as a gradually progressive m ental d et erio-
rat ion evide nce d by psychiatric dis tu rba nces; 36% ini tially pr esent with non specific
neu rol ogical sym p toms on ly; a nd the remai ning 23% of ca ses present with both
m ental and neurological prod romal-phase featu res (5). Wi th th e exce pt ion of brain
biopsy, there a re no specific test s for CJD. However , in th e la ter stages of the illn ess,
e lec t roe ncep halog ra m (EEG) is ofte n helpful in the diagn osis of CJ D, by demonstrat -
ing repetitive , high voltage, tri- a nd poly-phasic sharp di sch a rges. Because of suc h
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variable clinical presentations and the lack of specific diagnostic procedures , the
a n te mor te m di a gnosi s of CJD is difficult , and it is lik el y that many cases of this
disease r emain misdiagnosed during life.
Here we report a ca se ofCJD with a co m plicated initial p resentat io n w h ich led to
seve r a l psychiatric diagnoses over the course of one year prior to m a n ifes t at io n of
fo cal n eurologi c d eficits , d ementia , and positive EEG findin gs characterist ic of this
disea se.
CASE REPORT
A 44-year-old married woma n, with no past psychi atric histor y, but a signific ant family
hist ory of neurotic di sorders, was diagn osed with an a nxiety disorder in September 1988. Sh e
had develop ed panic a ttacks in th e con tex t of significant str esses in her marriage, and was
t reat ed int ermittently with a mitr ipty line and alprazo la m, with mi nimal improvement s.
By Sept ember 1989, th e patient 's sym ptoms had progr essed and she was now experi en cing
light head edness, whole body numbness, and abno rma l involuntary movem ents in th e left arm,
acco m pa nied by a n un st ead y gai t. Sh e was not ed to be forget ful and "clumsy," bumping in to
furni ture whil e walking. Sh e peri odi cally became unresponsive, stared blan kly into space, and
her business a ffairs became incr easingly chaot ic. Ne uro logical wor kup in a loca l hospit al ,
including br ain compute r ized tomogr aphy (CT) , magn etic reson an ce imaging (M RI) , and
ce re brospina l fluid (CSF) exa minat ion, was unrem arkable, exce pt for a n elect roe nce pha lo-
gra m (EEG) which showed minor nonsp ecific abnorma lit ies (slowed delta and the ta activity in
th e right front o-t emporal region ) . Meanwhile, th e pati en t 's con dition wors ened; she had
multiple fall s, was un abl e to con tro l body move me nts and ba la nce, and needed assist an ce in
ac tivities of daily life. She became depressed , with episodic pan ic a ttacks during which she a lso
became very ag ita ted a nd scr eamed , " Do n' t let me fall. "
In November 1989, sh e was referred to ano the r hospit al wher e neu rologic examination
reveal ed biza rr e cho reoa the to id movements of th e upper ex tremi ties , and a right ga ze
prefere nce with cerebella r signs. On mental sta tus examina t ion she was cogni tively int act but
appeare d to be sign ificantly depressed (Hamilton Dep ressive Sca le score : 39) . Once again,
com plete lab or at ory workup was unrem arkabl e exce pt for th e nonsp ecific minor abnormaliti es
on EEG. The differ ential diagnosis included : I) conve rs ion disorder; 2) adjus t ment d isorder ; or
3) a typical depression . She was pr escribed f1u oxetine 20 mg a day a nd clonazepam 0.5 mg twice
a day. The patient refused tr eatment a nd left th e hospit al agai nst me d ica l advic e, but becau se
of rapid det eri oration in her cond ition she was read mitted to another hospital shortly
th ereaft er. On admission, she was ag ita te d, confuse d, incoh erent , de pressed with psychotic
features (disor ganized th ought form, with visual/aud ito ry hallucin ation ), and she had devel-
op ed dysphagia . Sh e was treat ed bri efly with a neuroleptic (ha lope rido l) a nd a n an tidepressant
(do xe pine) with no improvem ent. The tr eatment was switched to electroconvulsive therapy ,
a nd she was given two treatmen ts followin g which she beca me m ute . Electroconvu lsive th erapy
was sto pped a nd th e patien t was tr an sferred to Univers ity Hospit als of C leve land in lat e
November 1989.
She was obs erv ed in a neurological unit wher e she was found to ha ve ma rked cognitive
impairment , gross a praxia, int ermittent ge ne ra lized myocloni c j erks and choreoathetoid
movem ents, ge ne ralized hyper-reflexi a , and unstead y ga it. Head CT and MRI showed paren-
chyma l a t ro phy (pro mine nt in left front al region ); EEG was grossly abnormal and revealed
ge ne ra lized slowing with bilat eral peri odic sha rp t ri phasic waves and epileptiform activity;
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CSF was unrem arkabl e except for sligh t ly decr eased pr ot ein; blood count revea led leu kocytosis
with left sh ift; and blood tests wer e remarkabl e on ly for incr eased cre a tine kinase activity and
incr ea sed erythrocyte sedimentation rat e. Ba sed on neurologic findin gs (especia lly myoclonic
j erks) , mental disturbances (especiall y memory deficit s a nd cog nit ive im pa irments) , a nd an
abnorma l EEG, a tentative di agn osis of ence pha lopa thy secondary to CJD was made. The
di agn osis was confirme d by brain biop sy whi ch discl osed pronounced spongiform cha nges a nd
mild as t rocyt ic proliferation with spared white matt er. Her hospit al course was st eadily
downhill until her death in Dec ember 1989. Postmortem microscopic exa mi na tio n of patient's
br ain also confirme d th e diagnosis of CJ D. It reveal ed spong iform degen era tion of neocor tex ,
co rpus striatum, a nd mol ecular layer of ce re be llu m, a nd an ea rly reactive astrocyto sis with
minimal neuronal loss, accompanied by a recent right temporal lobe wh ite ma tt er micro in-
fa rct .
DISC USSION
This cas e illustrates a patient with CJD, whos e complexity of prodromal
pr esentation obscured the ea rly diagnosis. The major fact ors th at led the physicians
to consider alternative psychi atric diagnoses during th e ea rly stages of the illness
were: I) a significant history of neurotic disorders in th e pa ti ent 's family; 2) mari tal
stresses whi ch coincided with the onset of psychiatric symptoms were cons t rue d as
th e contribu ting factor to pr esenting symptomatology a nd cloude d appre ciation of
neurological dis ease; and 3) th e variability of neurologic symptoms and incon sistency
in diagnostic tests, reinforcing th e possibility of a primary psychopathology.
The lit erature on CJD from th e early 1920s indicates that th e patients described
by Creutzfeldt and Jakob initially pr esented with psychi atric disturba nces severa l
months to yea rs prior to th e acute onse t of mental a nd neurological det eriora t ion.
Creutzfeldt described a 22-year-old wom an who appa re n t ly had a period of a no rexia
nervosa and "hysterical" attacks starting at age 21. As her illn ess pr ogr essed she
became depressed, and dev eloped personality changes, with marked manic-like
episodes. Late in the course of her illness she ex hibi ted biza rr e beh avior and
posturing, with paranoid and nihilisti c delu sions, and finall y developed severe cogni-
tive impairment and dementia . All four cases des cribed by J akob also had a past
history of anxiet y, and signs and symptoms of depression for severa l months pri or to
developing marked mental and neurological dysfun cti on. With th e pro gr ession of th e
illn ess, they demonstrated personality cha nge s, affectiv e dis orders with psychotic
features, and dementia. Verified CJD cases reported within th e last 50 yea rs also
suggest th e sa me pattern of psychiatric disturbances in a large number of th e
patients (6-9).
The biochemical model for psychiatric a nd cog nit ive disturban ces in CJ D is not
yet clear. CJD principally affects th e ce re bral cortex, putamen , ca uda te nucleus,
thalamus, and the mol ecular layer of ce re be llum. Investigators have debated over the
rol e of cent ra l neurotransmitter abnormalities in neurodegen erative disord ers involv-
ing ba sal gang lia and cere bral cortex. Some have spec ula te d that dopamine and
gamma-aminobutyric acid (GABA) dysfunction in th ese a reas may be res ponsible for
motor dysfunction, cognit ive impairments and dem entia, as well as th e psychi a tric
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disturbances seen in neurodegenerative disorders su ch as Parkinson 's d isease a nd
Huntington's disease (10-15). Several studies using positron e m ission tomography to
asses s the m etabolic rates in frontal co r tex and basal gang lia of pa t ie n ts with
affective illness have suggest ed that depressed pat ients a lso m ay be relatively
hyp od opaminergic (16,17) . Like othe r neurodegenerative di seases involving basal
ganglia and ce rebra l cor te x , decr eases in ce n t ral dopaminergic a nd GA BAergic
ac t ivity m ay be a con t r ibu t ing factor to the psy chiatric a nd neurol ogic dysfunct ion
seen in C]D.
Prions have been the su bject of much research and a tten t ion in recen t years.
M any advances hav e been m ade in d efining the molecular s t r uc t u re of the prions, and
in d eveloping specific immunost aining techniqu es to detect C] D prion protein
isoform in C]D-infect ed brain ex t racts (18,19). However, research on hu m a n C]D is
in it s infancy, and because m ost of the di agnostic procedures a re nonsp eci fic, or
reveal abnormality only in the lat er stages of the di sease , the early di agnosis remains
esse n tia lly clinical. W e conclud e that psychiatric symptoms a re co mmon in C] D and
may at tim es prec ed e the onset of n eurological deficit s. Therefore , we sugges t tha t
the following clinical picture should al ert the physician to the possible d iagnosis of
C] D : a ch ro nic hi st ory of anxiet y-d epressive illness with rapid progress ion of person-
a lity cha nges, cogn it ive impairment , and d epressive-psychotic illness, associat ed with
neurological dysfunction, evolving into a triad of dementia , myoclonus, a nd positive
EEG findings.
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